InTouch Bio (A Division of InTouch BioSolutions LLC) 2012 ©  All rights reserved.   

InTouch Bio now provides the reliable and robust unilateral 6-hydroxydopamine (6-OHDA) striatal or substantia nigra lesion rat model commonly used to study the neurodegenerative disease process associated with Parkinson's Disease (PD).

• Available for testing of new drug or device.
• Efficacy evaluation by rotation test and tyrosine hydroxylase activity (TH+) quantitation.

Preclinical Model of Parkinson’s Disease at InTouch Bio

• Drug efficacy evaluation

• Disease model development

• Fresh cells, tissues and organs harvest

• Compound PK/PD and toxicology evaluation

• Inflammation rodent models (e.g., CIA, EAE & IBD)

• Surgical and Neurology models (e.g., transplant / stereotactic)

• Cancer models (e.g., xenograft tumor and syngeneic tumor systems)

• Tissue and blood flow cytometry analysis and cell sorting/purification services

• High-throughput analyte measurements (e.g., ELISA, EIA) and cell-based analysis

Other Services